tiprankstipranks
Bristol-Myers Squibb Company (CH:BMY)
NYSE:BMY
Switzerland Market

Bristol-Myers Squibb (BMY) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
7Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
1Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Bristol-Myers Squibb Company’s (BMY) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Bristol-Myers Squibb Company is a Sell.
Bristol-Myers Squibb Company’s (BMY) 20-Day exponential moving average is 44.95, while Bristol-Myers Squibb Company’s (BMY) share price is CHF46.42, making it a Buy.
Bristol-Myers Squibb Company’s (BMY) 50-Day exponential moving average is 45.42, while Bristol-Myers Squibb Company’s (BMY) share price is CHF46.42, making it a Sell.

Bristol-Myers Squibb (BMY) Pivot Points

Jun 17, 2026, 11:53 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
44.41
44.80
45.00
45.39
45.59
45.98
46.18
Fibonacci
44.80
45.02
45.16
45.39
45.61
45.75
45.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bristol-Myers Squibb (BMY) Moving Averages

Jun 17, 2026, 11:53 AM
Period
Simple
Exponential
MA5
45.07Buy
45.08Buy
MA10
44.66Buy
44.95Buy
MA20
45.04Buy
44.95Buy
MA50
45.46Sell
45.42Sell
MA100
46.04Sell
46.61Sell
MA200
49.57Sell
49.00Sell
Bristol-Myers Squibb Company’s (BMY) 10-Day exponential moving average is 44.95, while Bristol-Myers Squibb Company’s (BMY) share price is CHF46.42, making it a Buy.
Bristol-Myers Squibb Company’s (BMY) 100-Day exponential moving average is 46.61, while Bristol-Myers Squibb Company’s (BMY) share price is CHF46.42, making it a Sell.
Bristol-Myers Squibb Company’s (BMY) stock price is CHF46.42 and Bristol-Myers Squibb Company’s (BMY) 50-day simple moving average is 45.46, creating a Sell signal.
Bristol-Myers Squibb Company’s (BMY) stock price is CHF46.42 and Bristol-Myers Squibb Company’s (BMY) 100-day simple moving average is 46.04, creating a Sell signal.
Bristol-Myers Squibb Company’s (BMY) stock price is CHF46.42 and Bristol-Myers Squibb Company’s (BMY) 200-day simple moving average is 49.57, creating a Sell signal.

Bristol-Myers Squibb (BMY) Technical Indicators

Jun 17, 2026, 11:53 AM
Name
Value
Implied Action
RSI (14)
51.35
Neutral
STOCH (9,6)
73.19
Neutral
STOCHRSI (14)
63.43
Neutral
MACD (12,26)
-0.08
Sell
Williams %R
-34.66
Buy
CCI (14)
-7.43
Neutral
ATR (14)
0.96
-
Ultimate Oscillator
55.24
Neutral
ROC
-2.19
Sell
Bull/Bear Power (13)
-0.13
Sell
Bristol-Myers Squibb Company’s (BMY) Relative Strength Index (RSI) is 51.35, creating a Neutral signal.
Bristol-Myers Squibb Company’s (BMY) Commodity Channel Index (CCI) is -7.43, creating a Neutral signal.
Bristol-Myers Squibb Company’s (BMY) Price Rate of Change (ROC) is -2.19, creating a Sell signal.

FAQ

Is BMY a Buy, Hold, or Sell?
Based on BMY’s technical indicators, BMY is a Hold.
    What is BMY’s RSI (14)?
    BMY’s RSI (14) is 51.35, which suggests BMY is a Neutral.
      What is BMY’s MACD?
      BMY’s MACD is -0.08, which suggests BMY is a Sell.
        What is BMY’s 5-day moving average?
        BMY’s 5-day moving average is 45.07, which suggests BMY is a Buy.
          What is BMY’s 20-day moving average?
          BMY 20-day moving average is 45.04, which suggests BMY is a Buy.
            What is BMY’s 50-day moving average?
            BMY’s 50-day moving average is 45.46, which suggests BMY is a Sell.
              What is BMY’s 200-day moving average?
              BMY’s 200-day moving average is 49.57, which suggests BMY is a Sell.
                What is BMY’s Williams % R (14)?
                BMY’s Williams % R (14) is -34.66, which suggests BMY is a Buy.
                  What is BMY’s CCI (14)?
                  BMY’s CCI (14) is -7.43, which suggests BMY is a Neutral.
                    What is the share price of Bristol-Myers Squibb Company?